Drug induced platelet refractoriness
WebFeb 20, 2024 · Multiple myeloma is a malignancy of immunoglobulin-secreting plasma cells that is now often treated in the newly diagnosed and relapsed and/or refractory settings with monoclonal antibodies targeting lineage-specific markers used either alone or in rationally designed combination regimens. Among these are the anti-CD38 antibodies … WebUnderstanding the pathogenesis of drug-induced immune thrombocytopenia is the key to better patient management. In this issue of Blood, Bougie and colleagues provide further useful insights into the
Drug induced platelet refractoriness
Did you know?
WebStatin-induced refractory thrombocytopenia is exceedly rare, with only a few case reports identified in the literature, with none previously reported with atorvastatin. A 2024 case report described the first known published case of a 69 YOF who developed refractory thrombocytopenia following atorvastatin use. WebMar 29, 2015 · Heparin-induced thrombocytopenic thrombosis is an uncommon, transient, drug-induced, autoimmune prothrombotic disorder caused by the formation of IgG antibodies that cause platelet activation by ...
WebIrradiation of both PRBCs and platelets -- prevents transfusion related graft vs host dz in immunocompromised patients and reduces refractoriness to platelet transfusions 3. ABO-compatible platelets -- Reduces refractoriness to platelet transfusions. What is the average circulating time for platelets? 5-10 days -- this is the reason for a nadir WebDec 4, 2024 · Refractoriness can be caused by immune and nonimmune factors, with nonimmune factors responsible for 60% to 80% of cases. 1 Immune factors, which play a role in 10% to 25% of patients with platelet refractoriness, include antibodies against …
WebOct 25, 2024 · Due to immune or nonimmune factors, platelet refractoriness may be observed and is defined as a repeated suboptimal response to platelet transfusions with lower-than-expected post-transfusion count increments. The management of patients with alloimmunization is complex and prophylactic platelet support is no longer indicated. WebPlatelet transfusion refractoriness (PTR) is defined as a response significantly lower than expected to at least two consecutive platelet transfusions ( 12 ). Typically, PTR can develop in patients with hematological cancers, who usually …
WebRefractoriness to platelet transfusion can be due to immune-mediated and/or non-immune mediated mechanisms. Antibody-mediated destruction of platelets can result from HLA antibodies, platelet autoantibodies (ITP or drug-induced thrombocytopenia) or rarely, antibodies directed against platelet-specific antigens.
WebAcquired abnormalities of platelet function are very common. Causes include. Drugs. Systemic disorders. Cardiopulmonary bypass. Acquired platelet dysfunction is suspected and diagnosed when unusual or prolonged bleeding is observed and other possible diagnoses (eg, thrombocytopenia, coagulation abnormalities) have been eliminated. phlegmon itemWebApr 11, 2024 · Multiple myeloma (MM) is an incurable cancer of the plasma cells. In the last twenty years, treatment strategies have evolved toward targeting MM cells—from the shotgun chemotherapy approach to the slightly more targeted approach of disrupting important MM molecular pathways to the immunotherapy approach that specifically … tst temas repetitivosWebUse of blood products in the critically ill. …or platelet products. The ratio of 1:1:1 (one unit plasma and one unit of platelets for each unit of RBCs) is typically used in trauma. In this … phlegmon oeilWebJun 18, 2015 · Rituximab, a monoclonal antibody targeting the CD20 antigen present on B lymphocytes, is often used in treating refractory or relapsed TTP with good response rates. 34-37 Most of the data are based on case reports and case series where rituximab was used concomitantly with other immunosuppressive agents. 23, 34, 36-42 A recent … phlegm on my chestWebPlatelet transfusion refractoriness is the repeated failure to achieve the desired level of blood platelets in a patient following a platelet transfusion.The cause of refractoriness … phlegmon of appendixWebJul 2, 2024 · Pathophysiology. Refractoriness is defined as the failure to obtain a satisfactory response to transfusion of unselected platelet components. One adult therapeutic dose (ATD) of platelets (four random pools or a single apheresis unit) typically raises the platelet count by 20-40×10 9 /L.. A platelet count increment of <10×10 9 /L … tst testing cdcWebJul 5, 2024 · Drug-induced thrombocytopenia: Withholding the causative drug usually results in improvement of platelet counts in cases of drug-induced thrombocytopenia. The mainstay of treatment in HIT is to … phlegmon of colon